Toseland CD - Search Results

1

Potential benefit of inhibitors of advanced glycation end products in the progression of type II diabetes: a study with aminoguanidine in C57/BLKsJ diabetic mice.

Piercy V, Toseland CD, Turner NC. Piercy V, et al. Among authors: toseland cd. Metabolism. 1998 Dec;47(12):1477-80. doi: 10.1016/s0026-0495(98)90073-7. Metabolism. 1998. PMID: 9867077

2

Acceleration of the development of diabetes in obese diabetic (db/db) mice by nicotinamide: a comparison with its antidiabetic effects in non-obese diabetic mice.

Piercy V, Toseland CD, Turner NC. Piercy V, et al. Among authors: toseland cd. Metabolism. 2000 Dec;49(12):1548-54. Metabolism. 2000. PMID: 11145115

3

Peroxisome proliferator-activated receptor-gamma agonist, rosiglitazone, protects against nephropathy and pancreatic islet abnormalities in Zucker fatty rats.

Buckingham RE, Al-Barazanji KA, Toseland CD, Slaughter M, Connor SC, West A, Bond B, Turner NC, Clapham JC. Buckingham RE, et al. Among authors: toseland cd. Diabetes. 1998 Aug;47(8):1326-34. doi: 10.2337/diab.47.8.1326. Diabetes. 1998. PMID: 9703335

4

Rosiglitazone prevents the onset of hyperglycaemia and proteinuria in the Zucker diabetic fatty rat.

Smith SA, Lister CA, Toseland CD, Buckingham RE. Smith SA, et al. Among authors: toseland cd. Diabetes Obes Metab. 2000 Dec;2(6):363-72. doi: 10.1046/j.1463-1326.2000.00099.x. Diabetes Obes Metab. 2000. PMID: 11225966

5

Effect of probucol on serum lipids, atherosclerosis and toxicology in fat-fed LDL receptor deficient mice.

Benson GM, Schiffelers R, Nicols C, Latcham J, Vidgeon-Hart M, Toseland CD, Suckling KE, Groot PH. Benson GM, et al. Among authors: toseland cd. Atherosclerosis. 1998 Dec;141(2):237-47. doi: 10.1016/s0021-9150(98)00177-4. Atherosclerosis. 1998. PMID: 9862172

6

Comparison of adipose tissue changes following administration of rosiglitazone in the dog and rat.

Toseland CD, Campbell S, Francis I, Bugelski PJ, Mehdi N. Toseland CD, et al. Diabetes Obes Metab. 2001 Jun;3(3):163-70. doi: 10.1046/j.1463-1326.2001.00117.x. Diabetes Obes Metab. 2001. PMID: 11412280

7

Neutropenia does not prevent etodolac- or indomethacin-induced gastrointestinal damage in the rat.

Melarange R, Gentry C, Toseland CD, Smith PH, Fuller J. Melarange R, et al. Among authors: toseland cd. Dig Dis Sci. 1995 Dec;40(12):2694-703. doi: 10.1007/BF02220462. Dig Dis Sci. 1995. PMID: 8536533

8

Study of the effects of cardiovascular drugs in heart cell cultures.

Toseland CD, Seaman CW, Francis I, White DJ, Earl LK. Toseland CD, et al. Toxicol In Vitro. 1996 Dec;10(6):765-73. doi: 10.1016/s0887-2333(96)00058-6. Toxicol In Vitro. 1996. PMID: 20650260

9

Effect of potent urease inhibitor, fluorofamide, on Helicobacter sp. in vivo and in vitro.

Pope AJ, Toseland CD, Rushant B, Richardson S, McVey M, Hills J. Pope AJ, et al. Among authors: toseland cd. Dig Dis Sci. 1998 Jan;43(1):109-19. doi: 10.1023/a:1018884322973. Dig Dis Sci. 1998. PMID: 9508511

10

Staphylococcal osteomyelitis--a comparison of co-amoxiclav with clindamycin and flucloxacillin in an experimental rat model.

Gisby J, Beale AS, Bryant JE, Toseland CD. Gisby J, et al. Among authors: toseland cd. J Antimicrob Chemother. 1994 Nov;34(5):755-64. doi: 10.1093/jac/34.5.755. J Antimicrob Chemother. 1994. PMID: 7706171

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

17 results

Search Page

Filters